223 related articles for article (PubMed ID: 15952770)
1. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin.
Jönsson TJ; Murray MS; Johnson LC; Poole LB; Lowther WT
Biochemistry; 2005 Jun; 44(24):8634-42. PubMed ID: 15952770
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine.
Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG
J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis and modeling of the peroxiredoxin (Prx) complex with the NMR structure of ATP-bound human sulfiredoxin implicate aspartate 187 of Prx I as the catalytic residue in ATP hydrolysis.
Lee DY; Park SJ; Jeong W; Sung HJ; Oho T; Wu X; Rhee SG; Gruschus JM
Biochemistry; 2006 Dec; 45(51):15301-9. PubMed ID: 17176052
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.
Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG
J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625
[TBL] [Abstract][Full Text] [Related]
5. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.
Jönsson TJ; Murray MS; Johnson LC; Lowther WT
J Biol Chem; 2008 Aug; 283(35):23846-51. PubMed ID: 18579529
[TBL] [Abstract][Full Text] [Related]
6. Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace.
Jönsson TJ; Johnson LC; Lowther WT
Nature; 2008 Jan; 451(7174):98-101. PubMed ID: 18172504
[TBL] [Abstract][Full Text] [Related]
7. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Rhee SG; Jeong W; Chang TS; Woo HA
Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin.
Jeong W; Park SJ; Chang TS; Lee DY; Rhee SG
J Biol Chem; 2006 May; 281(20):14400-7. PubMed ID: 16565085
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.
Lowther WT; Haynes AC
Antioxid Redox Signal; 2011 Jul; 15(1):99-109. PubMed ID: 20712415
[TBL] [Abstract][Full Text] [Related]
10. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
[TBL] [Abstract][Full Text] [Related]
11. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
[TBL] [Abstract][Full Text] [Related]
12. The Arabidopsis thaliana sulfiredoxin is a plastidic cysteine-sulfinic acid reductase involved in the photooxidative stress response.
Rey P; Bécuwe N; Barrault MB; Rumeau D; Havaux M; Biteau B; Toledano MB
Plant J; 2007 Feb; 49(3):505-14. PubMed ID: 17217469
[TBL] [Abstract][Full Text] [Related]
13. Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation.
Jönsson TJ; Johnson LC; Lowther WT
J Biol Chem; 2009 Nov; 284(48):33305-10. PubMed ID: 19812042
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of an archaeal peroxiredoxin from the aerobic hyperthermophilic crenarchaeon Aeropyrum pernix K1.
Mizohata E; Sakai H; Fusatomi E; Terada T; Murayama K; Shirouzu M; Yokoyama S
J Mol Biol; 2005 Nov; 354(2):317-29. PubMed ID: 16214169
[TBL] [Abstract][Full Text] [Related]
15. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin.
Biteau B; Labarre J; Toledano MB
Nature; 2003 Oct; 425(6961):980-4. PubMed ID: 14586471
[TBL] [Abstract][Full Text] [Related]
16. Reversal of 2-Cys peroxiredoxin oligomerization by sulfiredoxin.
Moon JC; Kim GM; Kim EK; Lee HN; Ha B; Lee SY; Jang HH
Biochem Biophys Res Commun; 2013 Mar; 432(2):291-5. PubMed ID: 23396059
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling.
Wood ZA; Poole LB; Karplus PA
Science; 2003 Apr; 300(5619):650-3. PubMed ID: 12714747
[TBL] [Abstract][Full Text] [Related]
18. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression.
Jeong W; Bae SH; Toledano MB; Rhee SG
Free Radic Biol Med; 2012 Aug; 53(3):447-56. PubMed ID: 22634055
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and solution NMR dynamics of a D (type II) peroxiredoxin glutaredoxin and thioredoxin dependent: a new insight into the peroxiredoxin oligomerism.
Echalier A; Trivelli X; Corbier C; Rouhier N; Walker O; Tsan P; Jacquot JP; Aubry A; Krimm I; Lancelin JM
Biochemistry; 2005 Feb; 44(6):1755-67. PubMed ID: 15697201
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxins and sulfiredoxin at the crossroads of the NO and H2O2 signaling pathways.
Abbas K; Riquier S; Drapier JC
Methods Enzymol; 2013; 527():113-28. PubMed ID: 23830628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
